health canada approval zepbound tirzepatide obesity canada 2024 2025 🇨🇦 has approved for the treatment of obstructive sleep apnea in adults Health Canada approves drug that

Acute kidney injury occurred in 0.5% of Zepbound-treated users versus 0.2% on placebo per the FDA prescribing information, and was generally tied to dehydration from severe vomiting or diarrhea not the drug itself

The safest approach is replacement

Just focus on these foundations: Strength training at least twice per week to protect muscle and keep metabolism strong High protein meals to support energy, recovery, and muscle during midlife Daily movement like walking, stretching, or low-impact cardio to help everything flow Hydration to reduce headaches, fatigue, and digestive discomfort Quality sleep to support hormones, mood, and recovery These habits dont make the medication work. They make you feel better while youre on it

This Tizepatide Lab Test provides you valuable insights into your metabolic health, total cholesterol, triglycerides, oxidative stress and more

If you drop the Pen on a hard surface, do not use it

Tirzepatide is the first in its class, being a single-molecule agonist of both the GLP-1 receptor and the receptor for glucose-dependent insulinotropic polypeptide (GIP), hence the term dual agonist or twincretin